Results for tag: "Eosinophilic Oesophagitis"

Eosinophilic Oesophagitis (EoE) is a chronic, immune-mediated disorder of the oesophagus, characterised by an infiltration of eosinophils. Symptoms include dysphagia, food impaction, heartburn, and chest pain. Diagnosis is based on endoscopic findings and biopsy. Treatment options include dietary modifications, topical corticosteroids, and proton pump inhibitors. EoE is a growing area of interest in the field of gastroenterology, with increasing prevalence and awareness. It is a complex disorder, with aetiology and pathogenesis still being investigated. Research is ongoing to identify biomarkers and develop new treatments. Companies in the EoE market include Allakos, Inc., AstraZeneca, Celgene Corporation, DBV Technologies, Regeneron Pharmaceuticals, Inc., Shire, and Takeda Pharmaceuticals. Show Less Read more